206 related articles for article (PubMed ID: 37121997)
1. TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Zorea J; Motro Y; Mazor RD; Carmi YK; Shulman Z; Mahajna J; Moran-Gilad J; Elkabets M
J Exp Clin Cancer Res; 2023 May; 42(1):107. PubMed ID: 37121997
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer.
Shakfa N; Li D; Conseil G; Lightbody ED; Wilson-Sanchez J; Hamade A; Chenard S; Jawa NA; Laight BJ; Afriyie-Asante A; Tyryshkin K; Koebel M; Koti M
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37015760
[TBL] [Abstract][Full Text] [Related]
3. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
Whillock AL; Ybarra TK; Bishop GA
J Biol Chem; 2021; 296():100465. PubMed ID: 33639170
[TBL] [Abstract][Full Text] [Related]
6. Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes.
Adams SF; Grimm AJ; Chiang CL; Mookerjee A; Flies D; Jean S; McCann GA; Michaux J; Pak H; Huber F; Neal C; Dangaj D; Bassani-Sternberg M; Rusakiewicz S; Facciabene A; Coukos G; Gimotty PA; Kandalaft LE
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817208
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model.
Pisano S; Lenna S; Healey GD; Izardi F; Meeks L; Jimenez YS; Velazquez OS; Gonzalez D; Conlan RS; Corradetti B
Clin Transl Med; 2021 Oct; 11(10):e551. PubMed ID: 34709744
[TBL] [Abstract][Full Text] [Related]
8. N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma.
Edwards SK; Moore CR; Liu Y; Grewal S; Covey LR; Xie P
BMC Cancer; 2013 Oct; 13():481. PubMed ID: 24131623
[TBL] [Abstract][Full Text] [Related]
9. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
11. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.
Xiu Y; Xu H; Zhao C; Li J; Morita Y; Yao Z; Xing L; Boyce BF
J Clin Invest; 2014 Jan; 124(1):297-310. PubMed ID: 24316970
[TBL] [Abstract][Full Text] [Related]
12. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
13. Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer.
Gomez S; Cox OL; Walker RR; Rentia U; Hadley M; Arthofer E; Diab N; Grundy EE; Kanholm T; McDonald JI; Kobyra J; Palmer E; Noonepalle S; Villagra A; Leitenberg D; Bollard CM; Saunthararajah Y; Chiappinelli KB
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343976
[TBL] [Abstract][Full Text] [Related]
14. Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.
Zhang J; Chen T; Yang X; Cheng H; Späth SS; Clavijo PE; Chen J; Silvin C; Issaeva N; Su X; Yarbrough WG; Annunziata CM; Chen Z; Van Waes C
Cancer Res; 2018 Aug; 78(16):4613-4626. PubMed ID: 29921694
[TBL] [Abstract][Full Text] [Related]
15. Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.
Hoover AA; Hufnagel DH; Harris W; Bullock K; Glass EB; Liu E; Barham W; Crispens MA; Khabele D; Giorgio TD; Wilson AJ; Yull FE
BMC Cancer; 2020 Oct; 20(1):970. PubMed ID: 33028251
[TBL] [Abstract][Full Text] [Related]
16. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
[TBL] [Abstract][Full Text] [Related]
17. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
18. Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR.
Li H; Hostager BS; Arkee T; Bishop GA
J Biol Chem; 2021 Sep; 297(3):101097. PubMed ID: 34418432
[TBL] [Abstract][Full Text] [Related]
19. The anti-tumor effect of OP-B on ovarian cancer in vitro and in vivo, and its mechanism: An investigation using network pharmacology-based analysis.
Yuan S; Xu Y; Yi T; Wang H
J Ethnopharmacol; 2022 Jan; 283():114706. PubMed ID: 34614446
[TBL] [Abstract][Full Text] [Related]
20. TIGIT enhances CD4
Chen F; Xu Y; Chen Y; Shan S
Cancer Med; 2020 May; 9(10):3584-3591. PubMed ID: 32212317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]